$2.88
At close: Nov 26, 4:58 PM EDT
$2.75
-0.13-4.50%
After Hours: 4:58 PM EDT
Comments
Loading...
Trevi Therapeutics (TRVI) Forecast
NewsEarningsTrevi Therapeutics (TRVI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTrevi Therapeutics (NASDAQ:TRVI) Stock Quotes, Forecast and News Summary
Trevi Therapeutics Stock (NASDAQ: TRVI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Trevi Therapeutics (TRVI) stock?
You can purchase shares of Trevi Therapeutics (NASDAQ:TRVI) through any online brokerage.
Who are Trevi Therapeutics (TRVI) competitors?
Other companies in Trevi Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), Xeris Biopharma Holdings (NASDAQ:XERS) and Terns Pharma (NASDAQ:TERN).
What is the forecast, or price target, for Trevi Therapeutics (TRVI) stock?
Trevi Therapeutics has a consensus price target of $8.73.
What is the current price for Trevi Therapeutics (TRVI)?
The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $2.7503 last updated November 26, 2024 at 4:58 PM EST.
Does Trevi Therapeutics (TRVI) pay a dividend?
There are no upcoming dividends for Trevi Therapeutics.
When is Trevi Therapeutics (NASDAQ:TRVI) reporting earnings?
Trevi Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Trevi Therapeutics (TRVI) going to split?
There is no upcoming split for Trevi Therapeutics.
What sector and industry does Trevi Therapeutics (TRVI) operate in?
Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.